MK

Megha Kiran Murme

Active Director Director DIN 11052250
DIN 11052250 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Megha Kiran Murme

Data last updated:

Megha Kiran Murme is a Director at New 365 Day & Night Pharmacy Limited (since 2025).

DIN 11052250
Primary Designation Director
First Appointment 11 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
New 365 Day & Night Pharmacy Limited U46497PN2025PLC240648
Director11 Apr 20252025Active

Board colleagues of Megha Kiran Murme

NameDINCompanyDesignation
Kiran Murme10060727New 365 Day & Night Pharmacy LimitedDirector
Manisha Suresh Tade11363428New 365 Day & Night Pharmacy LimitedAdditional Director

Directorship timeline

Open interactive timeline →
New 365 Day & Night Pharmacy Limited
Premium access

Shareholding and investment profile for Megha Kiran Murme

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Megha Kiran Murme

Megha Kiran Murme currently holds 1 directorship: New 365 Day & Night Pharmacy Limited (Director, since 11 Apr 2025).

Megha Kiran Murme was first appointed on 11 Apr 2025 as Director at New 365 Day & Night Pharmacy Limited.

The current boards of Megha Kiran Murme's companies include Kiran Murme (New 365 Day & Night Pharmacy Limited), Manisha Suresh Tade (New 365 Day & Night Pharmacy Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available